This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Rare Disease Conference 2026 - Rare Disease Summit
March 17-19, 2026
Pre-Conference Workshops on March 16, 2026Sheraton Philadelphia Downtown | Philadelphia, PA

Marsha Pelletier
Global Pipeline and BD Commercial Strategy at BioMarin Pharmaceutical Inc.
Speaker

Profile

At BioMarin, Marsha is Commercial Lead for several assets in the pipeline and Business Development as part of the Pipeline Commercial Strategy (PCS) team. Working within cross-functional teams is an integral part of this work to optimize asset planning/assessments and opportunity optimization. Prior to BioMarin, Marsha also has vast experience in Launch/Go-to-Market Strategy, Pricing & Market Access, Management and Portfolio Strategy work from Strategic Consulting firms such as Simon-Kucher & Partners, Health Advances, and LifeSciences Consultants. Marsha has an MPH from Columbia University in Global Healthcare Policy & Management and BA in Neuroscience and Pre-Med from Franklin & Marshall College.

Agenda Sessions

  • Orchestrating Cross-Functional Excellence – Breaking Silos in Rare Disease Commercialization

    4:30pm